Literature DB >> 19952741

Probiotics: progress toward novel therapies for intestinal diseases.

Fang Yan1, David Brent Polk.   

Abstract

PURPOSE OF REVIEW: As the beneficial effects of probiotics on health and disease prevention and treatment have been well recognized, the demand for probiotics in clinical applications and as functional foods has significantly increased in spite of limited understanding of the mechanisms. This review focuses on the most recent advances in probiotic research from genetics to biological consequences regulated by probiotics and probiotic-derived factors. RECENT
FINDINGS: Genomic and proteomic studies reveal genes and proteins involved in probiotic adaptation in the host and while exerting their beneficial effects. Recent studies in cell culture and in animal models emphasize probiotic functions in intestinal development, nutrition, host microbial balance, cytoprotection, barrier function, innate immunity, and inflammation. Most importantly, several novel and known probiotic-derived factors have been characterized, which regulate host-signaling pathways and mediate probiotic function.
SUMMARY: Progress in understanding probiotic mechanisms of action will increase our basic understanding of biological crosstalk and provide the rationale to support the development of new hypothesis-driven studies to define the clinical efficacy of probiotics for intestinal disorders.

Entities:  

Mesh:

Year:  2010        PMID: 19952741      PMCID: PMC3036989          DOI: 10.1097/MOG.0b013e328335239a

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  53 in total

1.  A cultured response to HIV.

Authors:  Melinda Wenner
Journal:  Nat Med       Date:  2009-06       Impact factor: 53.440

2.  Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis.

Authors:  Djahida Bouskra; Christophe Brézillon; Marion Bérard; Catherine Werts; Rosa Varona; Ivo Gomperts Boneca; Gérard Eberl
Journal:  Nature       Date:  2008-11-05       Impact factor: 49.962

3.  Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome.

Authors:  J Zeng; Y-Q Li; X-L Zuo; Y-B Zhen; J Yang; C-H Liu
Journal:  Aliment Pharmacol Ther       Date:  2008-07-30       Impact factor: 8.171

4.  Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC- and MAP kinase-dependent mechanism.

Authors:  A Seth; Fang Yan; D Brent Polk; R K Rao
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-02-21       Impact factor: 4.052

Review 5.  Probiotic and prebiotic supplementation for the prevention of neonatal necrotizing enterocolitis.

Authors:  M S Caplan
Journal:  J Perinatol       Date:  2009-05       Impact factor: 2.521

6.  Probiotics prevent enterohaemorrhagic Escherichia coli O157:H7-mediated inhibition of interferon-gamma-induced tyrosine phosphorylation of STAT-1.

Authors:  Narveen Jandu; Zoë Jingjing Zeng; Kathene C Johnson-Henry; Philip M Sherman
Journal:  Microbiology (Reading)       Date:  2009-02       Impact factor: 2.777

7.  Antimicrobial activity of a multispecies probiotic (Ecologic 641) against pathogens isolated from infected pancreatic necrosis.

Authors:  B U Ridwan; C J M Koning; M G H Besselink; H M Timmerman; E C Brouwer; J Verhoef; H G Gooszen; L M A Akkermans
Journal:  Lett Appl Microbiol       Date:  2007-10-15       Impact factor: 2.858

8.  Lactobacillus crispatus M247-derived H2O2 acts as a signal transducing molecule activating peroxisome proliferator activated receptor-gamma in the intestinal mucosa.

Authors:  Sandra Voltan; Diego Martines; Marina Elli; Paola Brun; Stefano Longo; Andrea Porzionato; Veronica Macchi; Renata D'Incà; Melania Scarpa; Giorgio Palù; Giacomo C Sturniolo; Lorenzo Morelli; Ignazio Castagliuolo
Journal:  Gastroenterology       Date:  2008-07-09       Impact factor: 22.682

9.  Probiotic administration in patients with ileal pouch-anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cells.

Authors:  Annamaria Pronio; Chiara Montesani; Cinzia Butteroni; Simona Vecchione; Gloria Mumolo; AnnaRita Vestri; Domenico Vitolo; Monica Boirivant
Journal:  Inflamm Bowel Dis       Date:  2008-05       Impact factor: 5.325

Review 10.  Nuclear factor-kappa B in intestinal protection and destruction.

Authors:  Martina E Spehlmann; Lars Eckmann
Journal:  Curr Opin Gastroenterol       Date:  2009-03       Impact factor: 3.287

View more
  28 in total

1.  Studies on host-foodborne bacteria in intestinal three-dimensional cell culture model indicate possible mechanisms of interaction.

Authors:  Marita Gimenez Pereira; Otávio Guilherme Gonçalves de Almeida; Hevelin Regiane Augusto da Silva; Marília Harumi Ishizawa; Elaine Cristina Pereira De Martinis
Journal:  World J Microbiol Biotechnol       Date:  2021-01-18       Impact factor: 3.312

2.  Probiotic pre-administration reduces mortality in a mouse model of cecal ligation and puncture-induced sepsis.

Authors:  Lufang Chen; Keying Xu; Qifeng Gui; Yue Chen; Deying Chen; Yunmei Yang
Journal:  Exp Ther Med       Date:  2016-07-20       Impact factor: 2.447

3.  Complete Genome Sequence of Bifidobacterium longum GT15: Identification and Characterization of Unique and Global Regulatory Genes.

Authors:  Natalia V Zakharevich; Olga V Averina; Ksenia M Klimina; Anna V Kudryavtseva; Artem S Kasianov; Vsevolod J Makeev; Valery N Danilenko
Journal:  Microb Ecol       Date:  2015-04-17       Impact factor: 4.552

4.  From probiotics to therapeutics: another step forward?

Authors:  Fayez K Ghishan; Pawel R Kiela
Journal:  J Clin Invest       Date:  2011-05-23       Impact factor: 14.808

5.  Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism.

Authors:  Fang Yan; Hanwei Cao; Timothy L Cover; M Kay Washington; Yan Shi; LinShu Liu; Rupesh Chaturvedi; Richard M Peek; Keith T Wilson; D Brent Polk
Journal:  J Clin Invest       Date:  2011-05-23       Impact factor: 14.808

6.  Toward an Alternative Therapeutic Approach for Skin Infections: Antagonistic Activity of Lactobacilli Against Antibiotic-Resistant Staphylococcus aureus and Pseudomonas aeruginosa.

Authors:  Mohamed M Hafez; Ibrahim A Maghrabi; Noha M Zaki
Journal:  Probiotics Antimicrob Proteins       Date:  2013-09       Impact factor: 4.609

7.  Quantitative Appraisal of the Probiotic Attributes and In Vitro Adhesion Potential of Anti-listerial Bacteriocin-producing Lactic Acid Bacteria.

Authors:  Sandipan Mukherjee; Atul Kumar Singh; Manab Deb Adhikari; Aiyagari Ramesh
Journal:  Probiotics Antimicrob Proteins       Date:  2013-06       Impact factor: 4.609

8.  Lactulose and Lactobacillus plantarum, a potential complementary synbiotic to control postweaning colibacillosis in piglets.

Authors:  A A Guerra-Ordaz; G González-Ortiz; R M La Ragione; M J Woodward; J W Collins; J F Pérez; S M Martín-Orúe
Journal:  Appl Environ Microbiol       Date:  2014-06-06       Impact factor: 4.792

Review 9.  Probiotic mediated NF-κB regulation for prospective management of type 2 diabetes.

Authors:  Rabia Bhardwaj; Brij Pal Singh; Nitika Sandhu; Niharika Singh; Ravinder Kaur; Namita Rokana; Kumar Siddharth Singh; Vishu Chaudhary; Harsh Panwar
Journal:  Mol Biol Rep       Date:  2020-01-09       Impact factor: 2.316

10.  A Lactobacillus rhamnosus GG-derived soluble protein, p40, stimulates ligand release from intestinal epithelial cells to transactivate epidermal growth factor receptor.

Authors:  Fang Yan; Liping Liu; Peter J Dempsey; Yu-Hwai Tsai; Elaine W Raines; Carole L Wilson; Hailong Cao; Zheng Cao; LinShu Liu; D Brent Polk
Journal:  J Biol Chem       Date:  2013-09-16       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.